| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/19/2013 | US20130245065 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium |
| 09/19/2013 | US20130245064 Novel neurotrypsin inhibitors |
| 09/19/2013 | US20130245062 Nitrile derivatives and their pharmaceutical use and compositions |
| 09/18/2013 | EP2638014A2 Tetrahydroquinoline and related bicyclic compounds for inhibition of ror activity and the treatment of disease |
| 09/18/2013 | EP2638013A1 Novel polymorphs of pitavastatin calcium |
| 09/18/2013 | EP2638008A1 Lactam derivatives useful as orexin receptor antagonists |
| 09/18/2013 | CN103313970A Novel bicyclic compound or salt thereof |
| 09/18/2013 | CN103304477A Purification method of 8-hydroxyquinoline crude product |
| 09/18/2013 | CN103304428A Amine-based compound, organic light-emitting diode including the same, and organic light-emitting apparatus including the amine-based compound |
| 09/18/2013 | CN102532016B 5-aminoquinoline-2(1H) ketone compound and synthetic method and application thereof |
| 09/18/2013 | CN101855201B Oxime esters and photopolymerization initiators containing the same |
| 09/17/2013 | US8536229 Acetylene derivatives having MGluR 5 antagonistic activity |
| 09/17/2013 | CA2570903C N-hydroxyamide derivatives and use thereof |
| 09/17/2013 | CA2498644C Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 09/12/2013 | WO2013102936A4 N-(3-((diethylamino) methyl)-4-hydroxyphenyl)-n-(quinolin-4-yl) sulfonamides for the treatment of tuberculosis and process of preparation thereof |
| 09/12/2013 | US20130237708 Optically Active Cyclic Alcohol Compound And Method For Preparing The Same |
| 09/12/2013 | US20130237563 Novel polymorphs of pitavastatin calcium |
| 09/12/2013 | US20130237531 Compounds and methods for kinase modulation, and indications therefor |
| 09/12/2013 | US20130237528 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/12/2013 | US20130236969 Use of Compounds for Inducing Differentiation of Mesenchymal Stem Cells to Chondrocytes |
| 09/11/2013 | EP2635554A2 Novel neurotrypsin inhibitors |
| 09/11/2013 | EP2635280A2 Cytosine deaminase modulators for enhancement of dna transfection |
| 09/11/2013 | CN103298790A Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof |
| 09/11/2013 | CN103298789A Heterocyclic compounds as imaging probes of tau pathology |
| 09/11/2013 | CN103288871A Intermediate for preparing dihydroxy acid HMG-CoA reductase inhibitor, and preparation method and applications thereof |
| 09/11/2013 | CN103288729A 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-l-hydroxyethyl)-8-hydroxyquin olin-2(1h)-one and its use in the treatment of pulmonary diseases |
| 09/11/2013 | CN103288728A Naphthoyl amine derivative, and preparation method and application thereof |
| 09/11/2013 | CN103288727A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/11/2013 | CN103288726A Long chain quinoline hydrazone gel factor, metal gel preparation thereof an application thereof for detecting cyanide ions |
| 09/11/2013 | CN103288660A N-methylation method of aromatic amine |
| 09/11/2013 | CN102086211B Aromatic heterocyclic compounds serving as protein kinase inhibitor |
| 09/11/2013 | CN101993416B Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound |
| 09/10/2013 | US8530469 Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 |
| 09/10/2013 | CA2700690C Process for producing reformatsky reagent in stable form |
| 09/10/2013 | CA2595522C 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 09/05/2013 | US20130231367 Beta2-adrenoreceptor agonists |
| 09/05/2013 | US20130231333 Estrogen receptor modulators and uses thereof |
| 09/04/2013 | EP2634177A1 Tau imaging probe |
| 09/04/2013 | CN103275002A Preparation method of pelitinib |
| 09/04/2013 | CN103275001A Preparation method of 4-amino-3-quinoidine formonitrile derivative |
| 09/04/2013 | CN103275000A Preparation method of rebamipide eutectic |
| 09/04/2013 | CN103274999A 3-halogenated quinolone derivative and preparation method thereof |
| 09/03/2013 | US8524908 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
| 09/03/2013 | US8524907 Methods of synthesizing pharmaceutical salts of a factor Xa inhibitor |
| 09/03/2013 | US8524894 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 09/03/2013 | US8524740 Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives |
| 09/03/2013 | US8524739 Quinoline derivatives and uses thereof |
| 09/03/2013 | US8524697 C20-C21 substituted glucocorticoid receptor agonists |
| 09/03/2013 | CA2572153C Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 08/29/2013 | WO2013126608A1 Sulfonamide compounds and uses as tnap inhibitors |
| 08/29/2013 | US20130225815 Fluoroalkylation Methods And Reagents |
| 08/29/2013 | US20130225621 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein |
| 08/29/2013 | US20130225610 Antimetastatic compounds |
| 08/29/2013 | US20130225524 Chemical Compounds |
| 08/29/2013 | US20130224760 Zinc-Responsive Peptides, and Methods of Use Thereof |
| 08/29/2013 | US20130224137 Skin lightening compositions |
| 08/29/2013 | US20130224136 Chiral compounds, compositions, products and methods employing same |
| 08/28/2013 | EP2630124A1 Tetrahydroquinoline derivatives used as ampk activators |
| 08/28/2013 | CN103265483A Co-crystal of norfloxacin and phthalic acid and preparation method thereof |
| 08/28/2013 | CN103265482A Preparation method of bosutinib |
| 08/28/2013 | CN103265481A Preparation method of 4-amino-3-quinoline formonitrile derivative |
| 08/28/2013 | CN103265480A Quinolinedione derivative, and preparation method and use thereof |
| 08/28/2013 | CN102470133B Quinoline derivative-containing pharmaceutical composition |
| 08/28/2013 | CN101423492B Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 08/27/2013 | US8519164 Process and intermediate compounds useful in the preparation of statins |
| 08/27/2013 | US8519158 Androgen receptor modulator compounds and methods |
| 08/22/2013 | WO2013081400A3 Novel benzamide derivative and use thereof |
| 08/22/2013 | WO2013028132A9 Chiral phosphines for palladium-catalyzed asymmetric alpha-arylation of ester enolates to produce tertiary stereocenters in high enantioselectivity |
| 08/22/2013 | US20130217881 Novel compounds having auditory protective effect |
| 08/22/2013 | US20130217724 N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof |
| 08/22/2013 | US20130217685 Compounds for modulating rna binding proteins and uses therefor |
| 08/22/2013 | US20130217678 Pharmaceutical agent comprising quinolone compound |
| 08/22/2013 | US20130217671 Quinoline derivatives and melk inhibitors containing the same |
| 08/21/2013 | EP2627640A1 Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 08/21/2013 | EP2627638A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
| 08/21/2013 | CN103261166A Method for producing 2,2,4-trimethyl-1,2-dihydroquinoline polymer-containing compositions |
| 08/21/2013 | CN103254129A Intergrase inhibitor |
| 08/21/2013 | CN103254128A Water-soluble fluorescent probe for naked eye and light enhancement detection of mercury ions and synthesis and application thereof |
| 08/21/2013 | CN102114432B Composite solid acid catalyst and preparation method and uses |
| 08/21/2013 | CN102036963B Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| 08/21/2013 | CN101817799B Cyanoacrylate compound and application thereof in pesticide and medicine |
| 08/21/2013 | CN101784533B 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 08/21/2013 | CN101193862B Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 08/20/2013 | US8513421 Substituted hydroxamic acids and uses thereof |
| 08/20/2013 | US8513418 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 08/20/2013 | US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors |
| 08/20/2013 | US8513239 Chiral cis-imidazolines |
| 08/20/2013 | CA2698825C Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection |
| 08/15/2013 | US20130210844 BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS |
| 08/15/2013 | US20130210801 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| 08/15/2013 | US20130210158 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 08/14/2013 | CN103249800A Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 08/14/2013 | CN103249722A Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 08/14/2013 | CN103242826A C3 symmetrical fluorescent molecular probe as well as preparation method and application thereof |
| 08/14/2013 | CN103242231A Quinoline derivatives as well as preparation methods and applications thereof |
| 08/14/2013 | CN103242230A Quinolinone derivative and preparation method thereof |
| 08/14/2013 | CN103242229A Synthesis method of PET (polyethylene terephthalate) developer THK523 precursor applicable to field of neurodegenerative diseases |
| 08/14/2013 | CN103242167A Amine compound, electrophotographic photoconductor, image forming method, image forming apparatus, and process cartridge |
| 08/14/2013 | CN101687796B Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 08/13/2013 | US8507722 Hepatitis C virus inhibitors |